Please login to the form below

Not currently logged in
Email:
Password:

F-star Alpha

This page shows the latest F-star Alpha news and features for those working in and with pharma, biotech and healthcare.

BMS taps F-star Alpha for immuno-oncology drug

BMS taps F-star Alpha for immuno-oncology drug

BMS taps F-star Alpha for immuno-oncology drug. Drug in development for breast and stomach cancers. ... Bristol-Myers Squibb (BMS) has hatched a plan to buy Austrian biotech F-star Alpha in order to claim rights to FS102, a drug in development for

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    525. F-star Alpha/BMS. Option to acquire F-star Alpha. Includes FS102 a P1 ready treatment for HER2 positive patients with breast / gastric cancer.

  • Pharma deals during October 2014 Pharma deals during October 2014

    This month is no exception with Bristol-Myers Squibb (BMS) securing an exclusive option to acquire F-star Alpha gaining access to its lead candidate FS102 for HER-2 positive patients

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics